Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes.

Liu Y, Ji L, Eno M, Kudalkar S, Li AL, Schimpgen M, Benchama O, Morales P, Xu S, Hurst D, Wu S, Mohammad KA, Wood JT, Zvonok N, Papahatjis DP, Zhou H, Honrao C, Mackie K, Reggio P, Hohmann AG, Marnett LJ, Makriyannis A, Nikas SP.

J Med Chem. 2018 Oct 11;61(19):8639-8657. doi: 10.1021/acs.jmedchem.8b00611. Epub 2018 Sep 21.

PMID:
30196704
2.

Albumin-Oxanorbornadiene Conjugates Formed ex Vivo for the Extended Circulation of Hydrophilic Cargo.

Higginson CJ, Eno MR, Khan S, Cameron MD, Finn MG.

ACS Chem Biol. 2016 Aug 19;11(8):2320-7. doi: 10.1021/acschembio.6b00444. Epub 2016 Jun 27.

3.

Nickel-Catalyzed Asymmetric Kumada Cross-Coupling of Symmetric Cyclic Sulfates.

Eno MS, Lu A, Morken JP.

J Am Chem Soc. 2016 Jun 29;138(25):7824-7. doi: 10.1021/jacs.6b03384. Epub 2016 Jun 16.

4.

P450 3A-Catalyzed O-Dealkylation of Lapatinib Induces Mitochondrial Stress and Activates Nrf2.

Eno MR, El-Gendy Bel-D, Cameron MD.

Chem Res Toxicol. 2016 May 16;29(5):784-96. doi: 10.1021/acs.chemrestox.5b00524. Epub 2016 Apr 8.

PMID:
26958860
5.

Enantioselective Hydroformylation of 1-Alkenes with Commercial Ph-BPE Ligand.

Yu Z, Eno MS, Annis AH, Morken JP.

Org Lett. 2015 Jul 2;17(13):3264-7. doi: 10.1021/acs.orglett.5b01421. Epub 2015 Jun 19.

6.

13-Methylarachidonic acid is a positive allosteric modulator of endocannabinoid oxygenation by cyclooxygenase.

Kudalkar SN, Nikas SP, Kingsley PJ, Xu S, Galligan JJ, Rouzer CA, Banerjee S, Ji L, Eno MR, Makriyannis A, Marnett LJ.

J Biol Chem. 2015 Mar 20;290(12):7897-909. doi: 10.1074/jbc.M114.634014. Epub 2015 Feb 2.

7.

AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.

Keenan CM, Storr MA, Thakur GA, Wood JT, Wager-Miller J, Straiker A, Eno MR, Nikas SP, Bashashati M, Hu H, Mackie K, Makriyannis A, Sharkey KA.

Br J Pharmacol. 2015 May;172(9):2406-18. doi: 10.1111/bph.13069. Epub 2015 Feb 27.

8.

Gauging reactive metabolites in drug-induced toxicity.

Eno MR, Cameron MD.

Curr Med Chem. 2015;22(4):465-89. Review.

PMID:
25174933
9.
10.

Inferior vena cava filter placement and risk of hematogenous distant metastasis in ovarian cancer.

Matsuo K, Carter CM, Ahn EH, Prather CP, Eno ML, Im DD, Rosenshein NB.

Am J Clin Oncol. 2013 Aug;36(4):362-7. doi: 10.1097/COC.0b013e318248da32.

PMID:
22643565
11.

Significance of perioperative infection in survival of patients with ovarian cancer.

Matsuo K, Prather CP, Ahn EH, Eno ML, Tierney KE, Yessaian AA, Im DD, Rosenshein NB, Roman LD.

Int J Gynecol Cancer. 2012 Feb;22(2):245-53. doi: 10.1097/IGC.0b013e31823bd6db.

PMID:
22228425
12.

Evaluating professionalism, practice-based learning and improvement, and systems-based practice: utilization of a compliance form and correlation with conflict styles.

Ogunyemi D, Eno M, Rad S, Fong A, Alexander C, Azziz R.

J Grad Med Educ. 2010 Sep;2(3):423-9. doi: 10.4300/JGME-D-10-00048.1.

13.

Patient-reported symptoms and survival in ovarian cancer.

Matsuo K, Ahn EH, Prather CP, Eno ML, Im DD, Rosenshein NB.

Int J Gynecol Cancer. 2011 Dec;21(9):1555-65. doi: 10.1097/IGC.0b013e3182259c7f.

PMID:
21912266
14.

Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer.

Matsuo K, Eno ML, Ahn EH, Shahzad MM, Im DD, Rosenshein NB, Sood AK.

Am J Clin Oncol. 2011 Oct;34(5):488-93. doi: 10.1097/COC.0b013e3181ec5f4b.

15.

Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma.

Matsuo K, Eno ML, Im DD, Rosenshein NB, Sood AK.

Gynecol Oncol. 2010 Jan;116(1):61-5. doi: 10.1016/j.ygyno.2009.09.018. Epub 2009 Oct 17.

16.

Vulvar mucinous adenocarcinoma associated with Crohn's disease: report of two cases.

Matsuo K, Chi DS, Eno ML, Im DD, Rosenshein NB.

Gynecol Obstet Invest. 2009;68(4):276-8. doi: 10.1159/000245742. Epub 2009 Oct 10.

PMID:
19828998
18.

Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas.

Matsuo K, Eno ML, Im DD, Rosenshein NB.

Arch Gynecol Obstet. 2010 Feb;281(2):325-8. doi: 10.1007/s00404-009-1121-1. Epub 2009 May 20.

PMID:
19455347
19.

Pregnancy and genital sarcoma: a systematic review of the literature.

Matsuo K, Eno ML, Im DD, Rosenshein NB.

Am J Perinatol. 2009 Aug;26(7):507-18. doi: 10.1055/s-0029-1215428. Epub 2009 Mar 13. Review.

PMID:
19288396
20.

Primary peritoneal clear cell adenocarcinoma arising in previous abdominal scar for endometriosis surgery.

Matsuo K, Alonsozana EL, Eno ML, Rosenshein NB, Im DD.

Arch Gynecol Obstet. 2009 Oct;280(4):637-41. doi: 10.1007/s00404-009-0962-y. Epub 2009 Feb 15.

PMID:
19219617
21.

Massive retroperitoneal cyst during pregnancy: case report managed conservatively by percutaneous aspiration and review of literature.

Matsuo K, Eno ML, Walker T, Im DD, Rosenshein NB.

Am J Perinatol. 2009 Mar;26(3):215-9. doi: 10.1055/s-0028-1103032. Epub 2008 Nov 21. Review.

PMID:
19031356
22.

Treatment of postoperative ileus after bowel surgery with low-dose intravenous erythromycin.

Lightfoot AJ, Eno M, Kreder KJ, O'Donnell MA, Rao SS, Williams RD.

Urology. 2007 Apr;69(4):611-5.

PMID:
17445634
23.

The occupational therapist discusses aphasia.

GIDEN FM, ENO ML, BOSLEY EC.

Am J Occup Ther. 1950 Jul-Aug;4(4):160-3; passim. No abstract available.

PMID:
15425591

Supplemental Content

Support Center